Use of Crushed Glecaprevir/Pibrentasvir in Hepatitis C Positive Donor Heart Transplant Recipients

We describe our experience with immediate post-transplant use of GLE/PIB in relation to sustained virologic response (SVR) based on route of administration.

Source: The Journal of Heart and Lung Transplantation - March 31, 2020 Category: Transplant Surgery Authors: G. Waldman, E. Bethea, J. Gustafson, M. Cote, T. Gift, C. Rogers, S. Shao, M. Villavicencio, D. D'Alessandro, R. Chung, G. Lewis Tags: (211) Source Type: research